e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ProQR Therapeutics N.V. - Ordinary Shares
(NQ:
PRQR
)
1.950
-0.170 (-8.02%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ProQR Therapeutics N.V. - Ordinary Shares
< Previous
1
2
3
4
5
Next >
ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023
April 18, 2023
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
Via
Benzinga
Earnings Outlook For ProQR Therapeutics
↗
March 28, 2023
Via
Benzinga
Raymond James Bullish On This Penny Stock's Reprioritized Pipeline
↗
August 12, 2022
Via
Benzinga
Why Safe & Green Holdings Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket
↗
March 30, 2023
Gainers Boxed, Inc. (NYSE: BOXD) gained 43.3% to $0.2303 in pre-market trading after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S....
Via
Benzinga
S&P 500 Up 1%; Bluebird Bio Shares Plummet
↗
March 29, 2023
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Wednesday. The Dow traded up 0.74% to 32,632.35 while the NASDAQ rose 1.51% to 11,893.07. The S&P 500, also...
Via
Benzinga
Why Shares of ProQR Therapeutics Dropped on Wednesday
↗
March 29, 2023
The clinical-stage biotech released fourth-quarter and full-year earnings.
Via
The Motley Fool
Nasdaq Rises 1%; US Pending Home Sales Increase In February
↗
March 29, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded up 0.58% to 32,580.89 while the NASDAQ rose 1.09% to 11,843.85. The S&P...
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
March 29, 2023
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.
Via
Benzinga
US Stocks Open Higher, Dow Jumps Over 200 Points
↗
March 29, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining over 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.72% to 32,628.42 while the NASDAQ rose 1.33%...
Via
Benzinga
ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event
March 29, 2023
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing
March 14, 2023
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR to Present at Upcoming Scientific and Industry Conferences
March 07, 2023
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023
February 28, 2023
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
Tesla To $175? Here Are 10 Other Price Target Changes For Friday
↗
December 23, 2022
Oppenheimer cut CarMax, Inc. (NYSE: KMX) price target from $100 to $75. . Oppenheimer analyst Brian Nagel maintained an Outperform rating on the stock. CarMax shares fell 1.3% to $56.47 in pre-market...
Via
Benzinga
Dow Dips 600 Points; AMC Entertainment Shares Plunge
↗
December 22, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 600 points on Thursday.
Via
Benzinga
SKLZ Stock Alert: Will Skillz Shares Get Delisted?
↗
December 22, 2022
Skillz (SKLZ) stock is worth checking on today as the company received a delisting notice from the New York Stock Exchange.
Via
InvestorPlace
Why Are Chinese EV Stocks NIO, XPEV, LI on Watch Today?
↗
December 22, 2022
Chinese electric vehicle (EV) stocks are a chief concern among investors today as these shares see mixed trading on Thursday!
Via
InvestorPlace
Why Is ProQR (PRQR) Stock Up 83% Today?
↗
December 22, 2022
ProQR (PRQR) stock is rising on Thursday thanks to an expanded licensing and collaboration agreement with Eli Lilly (LLY).
Via
InvestorPlace
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
↗
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher
↗
December 22, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 600 points on Thursday.
Via
Benzinga
Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3
↗
December 22, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday.
Via
Benzinga
ProQR Therapeutics Shares Soar As Eli Lilly Expands RNA Collaboration
↗
December 22, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
December 22, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Thursday!
Via
InvestorPlace
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform
December 22, 2022
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
Lilly and ProQR to Expand RNA Editing Collaboration
December 22, 2022
New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQR’s Axiomer technology
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022
November 14, 2022
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Third Quarter 2022 Operating and Financial Results
November 09, 2022
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference
November 03, 2022
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
↗
August 12, 2022
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.